Welcome to MacKenzie Realty Capital, Inc. Financial Results for the Second Quarter Ended December 31, 2025 ORINDA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) MacKenzie Realty Capital, Inc. (Nasdaq: MKZR), also known as MacKenzie, has announced their financial results for the second quarter ended December 31, 2025. This is an exciting time for the company as…
Apogee Therapeutics: Exciting Interim Results Ahead for Novel Biologics in Inflammatory and Immunology Markets Apogee Therapeutics, a pioneering clinical-stage biotech company, is set to make waves in the healthcare industry with its innovative approach to treating some of the largest inflammatory and immunology (I&I) conditions. The company’s focus includes atopic dermatitis (AD), asthma, eosinophilic esophagitis…
Zhao Changpeng’s vote addresses critical MEV issues on BNB Chain The Issue Miner Extractable Value (MEV) issues have been a hot topic in the world of blockchain and cryptocurrencies. MEV refers to the profits that miners can make by reordering or censoring transactions in a block. This can lead to frontrunning, sandwich attacks, and other…
Latest SEC Filings: A New Wave of Applications from Issuers and Exchanges The Securities and Exchange Commission (SEC) has been receiving a significant number of filings from issuers and exchanges lately. This trend is not new, as the SEC has always been a hub for companies seeking to raise capital and list their securities. However,…
FAVO Capital, Inc. Files Form S-1 Registration Statement for Uplisting to Nasdaq Capital Market Introduction FORT LAUDERDALE, Fla., Feb. 18, 2025 (GLOBE NEWSWIRE) — via IBN — FAVO Capital, Inc. (OTC: FAVO), a private credit firm providing alternative financing solutions to small and medium-sized businesses (SMBs), today announced that it has filed a Form S-1…
CS Diagnostics Corp. Announces Appointment of Lachman Consultants for FDA Approval Support CS Diagnostics Corp. (CSDX), a leading innovator in the field of tissue spacers for cancer radiology treatments, is thrilled to announce the engagement of Lachman Consultants Inc. to provide regulatory expertise and guidance in the company’s quest for Food and Drug Administration (FDA)…
Investing New Money: A Winning Strategy The Power of Regularly Investing New Money Many successful investors have a unique strategy that sets them apart from the rest – they regularly invest new money. This approach to the stock market is often under-appreciated, but it has proven to be a winning strategy for those who have…
Warren Buffett’s Preference for Equities: Implications for Investors and the World In his annual letter to shareholders, published in February 2024, Oracle of Omaha, Warren Buffett, reaffirmed his commitment to equities as the preferred investment vehicle for Berkshire Hathaway. This announcement comes as no surprise to those familiar with Buffett’s investment philosophy, which has long…
